New York A10747 mandates health insurance plans to cover a medically necessary peripheral artery disease screening test for at-risk individuals and.

New York A10747 amends the insurance law to require health insurance plans to cover a medically necessary peripheral artery disease screening test for any at-risk individual, as defined by the American College of Cardiology and the American Heart Association's joint committee on clinical practice guidelines. The bill also prohibits these plans from imposing patient cost sharing for follow-up screenings or diagnostic services related to peripheral artery disease. This requirement applies to all policies and contracts issued, renewed, modified, altered, or amended on or after January 1, 2027.

New York A10747 mandates health insurance plans to cover a medically necessary peripheral artery disease screening test for at-risk individuals and.

New York A10747 amends the insurance law to require health insurance plans to cover a medically necessary peripheral artery disease screening test for any at-risk individual, as defined by the American College of Cardiology and the American Heart Association's joint committee on clinical practice guidelines. The bill also prohibits these plans from imposing patient cost sharing for follow-up screenings or diagnostic services related to peripheral artery disease. This requirement applies to all policies and contracts issued, renewed, modified, altered, or amended on or after January 1, 2027.